FDA Warning Letter — Enrite

Case 685074 — FEI 3021166064

The FDA took a Warning Letter action against Enrite on May 23, 2024 (Manalapan, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Enrite
Date
May 23, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Manalapan, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.